Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic Leukemia

Overview of attention for article published in Blood Cancer Discovery, May 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 7,497 followers.

Commentary: Genomics, Transcriptomics, and Minimal Residual Disease Detection—The Winning Team to Guide Treatment of Acute Lymphoblastic #Leukemia. #hemepath #leusm. @Onco_KULeuven @CoolsJn https://t.co/ShcpeHLSHn https://t.co/Lgj3t9Io4H

RT @BCD_AACR: #OnlineFirst Commentary - Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatm…

RT @BCD_AACR: #OnlineFirst Commentary - Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatm…

RT @BCD_AACR: #OnlineFirst Commentary - Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatm…

#OnlineFirst Commentary - Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic #Leukemia #hemepath #leusm. @Onco_KULeuven @CoolsJn https://t.co/fRDENG3eQl https://t.co/Ud5aBtKUWm